Prelude Therapeutics Inc (PRLD)

Finanzdaten der Prelude Therapeutics Inc-Aktie (PRLD)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	-	-	-	-	-
Operating Expenses	8.12% 34.34	37.38	33.38	32.40	29.11
Operating Income/Loss	8.12% -34.34	-37.38	-33.38	-32.40	-29.11
Income/Loss From Continuing Operations Before Tax	4.97% -31.43	-33.08	-30.61	-30.43	-27.72
Income/Loss From Continuing Operations After Tax	4.97% -31.43	-33.08	-30.61	-30.43	-27.72
Net Income/Loss	4.97% -31.43	-33.08	-30.61	-30.43	-27.72
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	2,360% 75.74	3.0783	67.64	56.24	47.74
Diluted Average Shares	2,360% 75.74	3.0783	67.64	56.24	47.74
Basic Earnings Per Share	10.64% -0.42	-0.47	-0.45	-0.54	-0.58
Diluted Earnings Per Share	10.64% -0.42	-0.47	-0.45	-0.54	-0.58
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-